Zanolimumab (HuMax-CD4 (TM)), a fully human monoclonal antibody: Efficacy and safety in patients with relapsed or treatment-refractory non-cutaneous CD4(+) T-cell lymphoma

LIBRIS Formathandbok (Information om MARC21)

Fältnamn	Indikatorer	Metadata
000		01344naa a2200361 4500
001		oai:prod.swepub.kib.ki.se:116630816
003		SwePub
008		240701s2007 \| \|\|\|\|\|\|\|\|\|\|\|000 \|\|eng\|
024	7	a http://kipublications.ki.se/Default.aspx?queryparsed=id:1166308162 URI
024	7	a https://doi.org/10.1182/blood.V110.11.3409.34092 DOI
040		a (SwePub)ki
041		a eng
042		9 SwePub
072	7	a vet2 swepub-contenttype
072	7	a kon2 swepub-publicationtype
100	1	a d'Amore, F4 aut
245	1 0	a Zanolimumab (HuMax-CD4 (TM)), a fully human monoclonal antibody: Efficacy and safety in patients with relapsed or treatment-refractory non-cutaneous CD4(+) T-cell lymphoma
264	1	c 2007
700	1	a Radford, J4 aut
700	1	a Jerkeman, M4 aut
700	1	a Relander, T4 aut
700	1	a Tilly, H4 aut
700	1	a Osterborg, Au Karolinska Institutet4 aut
700	1	a Morschhauser, F4 aut
700	1	a Gramatzki, M4 aut
700	1	a Dreyling, M4 aut
700	1	a Bang, B4 aut
700	1	a Baadsgaard, O4 aut
700	1	a Hagberg, H4 aut
710	2	a Karolinska Institutet4 org
773	0	t BLOODg 110:11, s. 999A-999Aq 110:11<999A-999Ax 0006-4971
856	4 8	u http://kipublications.ki.se/Default.aspx?queryparsed=id:116630816
856	4 8	u https://doi.org/10.1182/blood.V110.11.3409.3409

By the author/editor: d'Amore, F; Radford, J; Jerkeman, M; Relander, T; Tilly, H; Osterborg, A; show more...; Morschhauser, F; Gramatzki, M; Dreyling, M; Bang, B; Baadsgaard, O; Hagberg, H; show less...

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.